Surgical outcomes in patients who received presurgical treatment with pazopanib for advanced renal cell carcinoma with inferior vena cava tumor thrombus; a historical control study
Latest Information Update: 14 Sep 2020
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 10 Sep 2020 Status has been changed to completed.
- 06 Dec 2018 New trial record